Serum cholesterol LDL and 90-day mortality in patients with intracerebral hemorrhage

Stroke

Volumn 40, Issue 5, 2009, Pages 1917-1920

  Ramírez Moreno, José María ^a   Casado Naranjo, Ignacio ^b   Portilla, Juan Carlos ^b   Calle, María Luisa ^b   Tena, David ^b   Falcón, Alfonso ^b   Serrano, Ana ^b  

^a HOSPITAL INFANTA CRISTINA   (Spain)

^b San Pedro de Alcantara Hospital   (Spain)

Author keywords

Cardiovascular disease; Cholesterol; Intracerebral haemorrhage; Low density lipoprotein cholesterol; Prognosis

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BRAIN HEMORRHAGE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HAZARD RATIO; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SURVIVAL RATE; AGED; ANALYSIS OF VARIANCE; BLOOD; FOLLOW UP; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RADIOGRAPHY; RISK FACTOR; STATISTICAL ANALYSIS; SURVIVAL; TREATMENT OUTCOME;

AGED; ANALYSIS OF VARIANCE; CEREBRAL HEMORRHAGE; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DATA INTERPRETATION, STATISTICAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL; TREATMENT OUTCOME;

EID: 65549156899     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.108.536698     Document Type: Article

References (11)

1. Tirschwell DL, Smith NL, Heckbert SR, Lemaitre RN, Longstreth WT Jr, Psaty BM. Association of cholesterol with stroke risk varies in stroke subtypes and patient subgroups. Neurology. 2004;63:1868-1875.
2. Goldstein LB, Amarenco P, Szarek M, Callahan A, Hennerici M, Sillesen H, Zivin JA, Welch KMA, On behalf of the SPARCL Investigators. Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study. Neurology. 2007;70:2364-2370.
3. Iso H, Jacobs DR, Wentworth D, Neaton JD; Cohen JD; for the MRFIT research group. Serum cholesterol levels and six-year mortality in 350,997 men screened for the multiple risk factor intervention trial. N Engl J Med. 1989;320:904-910.
4. Roquer J, Rodriguez-Campello A, Gomis M, Ois A, Munteis E, Bohm P. Serum lipid levels and in-hospital mortality in patients with intracerebral hemorrhage. Neurology. 2005;65:1198-1202.
5. Olsen TJ, Christensen BRH, Kammersgaard LP, Andersen KK. Higher total serum cholesterol levels are associated with less severe strokes and lower all-cause mortality: ten-year follow-up of ischemic strokes in the Copenhagen Stroke Study. Stroke. 2007;38:2646-2651.
6. Segal AZ, Chiu RI, Eggleston-Sexton PM, Beiser A, Greenberg SM. Low cholesterol as a risk factor for primary intracerebral hemorrhage: a case-control study. Neuroepidemiology. 1999;18:185-193.
7. Dyker AG, Weir CJ, Lees KR. Influence of cholesterol on survival after stroke: retrospective study. BMJ. 1997;314:1584-1588.
8. Anderson KM, Castelli WP, Levy D. Cholesterol and mortality. 30 years of follow-up from the Framingham study. JAMA. 1987;257:2176-2180.
9. Broderick JP, Diringer MN, Hill MD, Brun NC, Mayer SA, Steiner T, Skolnick BE, Davis SM; for the Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators. Determinants of intracere-bral hemorrhage growth: an exploratory analysis. Stroke. 2007;38: 072-1075.
10. Bang OY, Saver JL, Liebeskind DS, Starkman S, Villablanca P, Salamon N, Buck B, Ali L, Restrepo L, Vinuela F, Duckwiler G, Jahan R, Razinia T, Ovbiagele B. Cholesterol level and symptomatic hemorrhagic transformation after ischemic stroke thrombolysis. Neurology. 2007;68: 737-742.
11. Vergouwen MDI, de Haan RJ, Vermeulen M, Roos YBWEM. Statin treatment and the occurrence of hemorrhagic stroke in patients with a history of cerebrovascular disease. Stroke. 2008;39:497-502.